다우존스 지수

실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

등록

홈
인베스팅
주식
미국
NYSE
ADC Therapeutics SA (ADCT)
ADC Therapeutics SA (ADCT) 뉴스

ADCT

ADC Therapeutics (ADCT)

ADC Therapeutics SA

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NYSE:ADCT

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2025/03/28	04:34	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NYSE:ADCT	ADC Therapeutics SA
2025/03/28	04:28	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NYSE:ADCT	ADC Therapeutics SA
2025/03/27	20:39	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:ADCT	ADC Therapeutics SA
2025/03/27	20:30	PR Newswire (US)	ADC Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Operational Update	NYSE:ADCT	ADC Therapeutics SA
2025/03/26	06:30	PR Newswire (US)	ADC Therapeutics Announces Abstracts Accepted for Presentation at the American Association for Cancer Research Annual Meeting 2025	NYSE:ADCT	ADC Therapeutics SA
2025/03/20	20:15	PR Newswire (US)	ADC Therapeutics to Host Fourth Quarter and Year-End 2024 Financial Results Conference Call on March 27, 2025	NYSE:ADCT	ADC Therapeutics SA
2025/02/15	08:20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ADCT	ADC Therapeutics SA
2025/02/04	08:10	Edgar (US Regulatory)	Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors	NYSE:ADCT	ADC Therapeutics SA
2025/02/04	06:05	PR Newswire (US)	ADC Therapeutics Makes Grants to New Employees Under Inducement Plan	NYSE:ADCT	ADC Therapeutics SA
2025/01/30	21:15	PR Newswire (US)	ADC Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference	NYSE:ADCT	ADC Therapeutics SA
2025/01/14	02:20	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:ADCT	ADC Therapeutics SA
2025/01/03	06:05	PR Newswire (US)	ADC Therapeutics Makes Grants to New Employees Under Inducement Plan	NYSE:ADCT	ADC Therapeutics SA
2024/12/31	06:30	PR Newswire (US)	ADC Therapeutics Announces Completion of Enrollment of Phase 3 Confirmatory Clinical Trial of ZYNLONTA® in Combination with Rituximab in 2L+ Diffuse Large B-Cell Lymphoma	NYSE:ADCT	ADC Therapeutics SA
2024/12/11	21:30	PR Newswire (US)	ADC Therapeutics Announces Positive Initial Data from LOTIS-7 Clinical Trial Evaluating ZYNLONTA® in Combination with Bispecific Antibody in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma	NYSE:ADCT	ADC Therapeutics SA
2024/12/10	10:42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ADCT	ADC Therapeutics SA
2024/12/10	10:39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ADCT	ADC Therapeutics SA
2024/12/10	10:30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ADCT	ADC Therapeutics SA
2024/12/09	21:30	PR Newswire (US)	ADC Therapeutics Announces The Lancet Haematology Publication of Data from Investigator-Initiated Trial Evaluating ZYNLONTA® in Combination with Rituximab to Treat Relapsed/Refractory Follicular Lymphoma	NYSE:ADCT	ADC Therapeutics SA
2024/12/06	21:30	PR Newswire (US)	ADC Therapeutics to Provide Initial Data Update on LOTIS-7 Clinical Trial	NYSE:ADCT	ADC Therapeutics SA
2024/12/03	06:30	PR Newswire (US)	ADC Therapeutics Makes Grants to New Employees Under Inducement Plan	NYSE:ADCT	ADC Therapeutics SA
2024/11/08	00:44	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NYSE:ADCT	ADC Therapeutics SA
2024/11/07	21:54	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:ADCT	ADC Therapeutics SA
2024/11/07	21:30	PR Newswire (US)	ADC Therapeutics Reports Third Quarter and Year-to-Date 2024 Financial Results and Provides Operational Update	NYSE:ADCT	ADC Therapeutics SA
2024/11/05	23:47	PR Newswire (US)	ADC Therapeutics Announces Investigator-Initiated Study Abstracts Accepted for Presentation at the 66th ASH Annual Meeting	NYSE:ADCT	ADC Therapeutics SA
2024/11/04	21:15	PR Newswire (US)	ADC Therapeutics to Present at November Investor Conferences	NYSE:ADCT	ADC Therapeutics SA
2024/11/02	05:05	PR Newswire (US)	ADC Therapeutics Makes Grants to New Employees Under Inducement Plan	NYSE:ADCT	ADC Therapeutics SA
2024/10/31	20:15	PR Newswire (US)	ADC Therapeutics to Host Third Quarter 2024 Financial Results Conference Call on November 7, 2024	NYSE:ADCT	ADC Therapeutics SA
2024/10/02	05:05	GlobeNewswire Inc.	ADC Therapeutics Makes Grants to New Employees Under Inducement Plan	NYSE:ADCT	ADC Therapeutics SA
2024/09/24	05:39	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NYSE:ADCT	ADC Therapeutics SA
2024/09/24	05:35	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NYSE:ADCT	ADC Therapeutics SA

검색 관련기사 보기:NYSE:ADCT

1 2 3 4 5 6 7 8 9 10 다음 >>

Vontobel Financial Produ...

Invesco Markets

Lyxor Asset Management L...

Corp Nacion del Cobre de...

Vontobel Financial Produ...

Bmo Greater China Fund S...

Global Star Acquisition

Cartesian Therapeutics

Vontobel Financial Produ...

Aether Catalyst Solutions (PK)

Amundi MSCI World Financ...

Bmo Global Dividend Fund...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관